Simulations Plus dipped after Q3 2025 on guidance cuts, but core software strength and long-term growth drivers remain. Find ...

The Motley Fool. DATE Monday, July 14, 2025 at 5 p.m. EDT CALL PARTICIPANTS Chief Executive Officer -- Shawn O'ConnorChief ...

Shares of Simulations Plus, Inc SLP -9.85% Get Free Report fell sharply in pre-market trading after the company reported ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $26.5, a high estimate of $36.00, and a low estimate of $20.00. This current average represents a 31.17% ...

RESEARCH TRIANGLE PARK, N.C. (AP) — RESEARCH TRIANGLE PARK, N.C. (AP) — Simulations Plus Inc. (SLP) on Monday reported a loss of $67.3 million in its fiscal third quarter.

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications ...

Simulations Plus growth is steady, but its margins continue to decline. Check out why I remain neutral on SLP stock.

Simulations Plus launched its University+ Program offering students & educators at accredited universities free 1-year access to the company software.

Investing.com -- Simulations Plus , Inc. (NASDAQ: SLP ), a provider of biosimulation solutions for the biopharma industry, saw its shares surge up to 3.3% after reporting third quarter fiscal 2025 ...

Simulations Plus has reported impressive financial results for the first quarter of fiscal 2025, with a notable 31% year-over-year revenue growth, primarily driven by robust software sales.

Simulations Plus has a long track record of delivering consistent growth and margin expansion. However, the stock has been down due to concerns about the funding environment for biotechnology and ...

Q3 2025 Earnings Call Transcript July 14, 2025 Simulations Plus, Inc. beats earnings expectations. Reported EPS is $0.45, expectations were $0.26. Operator: Greetings, and welcome to the Simulations ...